Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Racemic Epinephrine for Dysphagia Prevention in ACDF
NCT02724761Unknown
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in dysphagia comparing Racemic Epinephrine with Placebo: 0.9% Normal Saline (2 arms). Primary endpoints: Dysphagia Numeric Rating Scale at 30 days and Visual Analogue Scale - Odynophagia at 30 days. Status: unknown.
02
Drugs
racepinephrine
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT02724761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724761.